ProQR Therapeutics Statistics
Total Valuation
PRQR has a market cap or net worth of $214.90 million. The enterprise value is $90.00 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRQR has 105.34 million shares outstanding. The number of shares has increased by 13.35% in one year.
| Current Share Class | 105.34M |
| Shares Outstanding | 105.34M |
| Shares Change (YoY) | +13.35% |
| Shares Change (QoQ) | +5.90% |
| Owned by Insiders (%) | 2.38% |
| Owned by Institutions (%) | 32.35% |
| Float | 66.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.42 |
| Forward PS | 13.07 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 2.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.21.
| Current Ratio | 4.10 |
| Quick Ratio | 4.01 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.84 |
Financial Efficiency
Return on equity (ROE) is -53.07% and return on invested capital (ROIC) is -27.71%.
| Return on Equity (ROE) | -53.07% |
| Return on Assets (ROA) | -15.07% |
| Return on Invested Capital (ROIC) | -27.71% |
| Return on Capital Employed (ROCE) | -28.15% |
| Revenue Per Employee | $127,710 |
| Profits Per Employee | -$196,414 |
| Employee Count | 166 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -216,169 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.64% in the last 52 weeks. The beta is 0.31, so PRQR's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +23.64% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 61.01 |
| Average Volume (20 Days) | 351,604 |
Short Selling Information
| Short Interest | 641,633 |
| Short Previous Month | 584,148 |
| Short % of Shares Out | 0.86% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.05 |
Income Statement
In the last 12 months, PRQR had revenue of $21.21 million and -$32.62 million in losses. Loss per share was -$0.36.
| Revenue | 21.21M |
| Gross Profit | 21.21M |
| Operating Income | -35.90M |
| Pretax Income | -23.79M |
| Net Income | -32.62M |
| EBITDA | -34.95M |
| EBIT | -35.90M |
| Loss Per Share | -$0.36 |
Full Income StatementBalance Sheet
The company has $143.12 million in cash and $18.22 million in debt, giving a net cash position of $124.90 million or $1.19 per share.
| Cash & Cash Equivalents | 143.12M |
| Total Debt | 18.22M |
| Net Cash | 124.90M |
| Net Cash Per Share | $1.19 |
| Equity (Book Value) | 85.32M |
| Book Value Per Share | 0.81 |
| Working Capital | 112.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.06 million and capital expenditures -$983,571, giving a free cash flow of -$44.50 million.
| Operating Cash Flow | -40.06M |
| Capital Expenditures | -983,571 |
| Free Cash Flow | -44.50M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -169.23% and -153.80%.
| Gross Margin | 100.00% |
| Operating Margin | -169.23% |
| Pretax Margin | -154.82% |
| Profit Margin | -153.80% |
| EBITDA Margin | -164.74% |
| EBIT Margin | -169.23% |
| FCF Margin | n/a |
Dividends & Yields
PRQR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.35% |
| Shareholder Yield | -13.35% |
| Earnings Yield | -15.18% |
| FCF Yield | -20.71% |
Analyst Forecast
The average price target for PRQR is $8.88, which is 335.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.88 |
| Price Target Difference | 335.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 47.02% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |